semaglutide and endurance athletes What to Know About GLP-1 Medications For Young SHOULD ENDURANCE ATHLETES USE GLP-1s?
Description
Triple-action peptide concept
The New York drug giant will go up against other big pharmas in the world's second-most populous country by lining up a deal with Sciwind Biosciences for its recently approved GLP-1 injectable called ecnoglutide
Not licensed for weight loss
This dual synthetic polypeptide, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 receptor agonist (GLP-1 RA) acts through incretin pathways and stimulates insulin sensitivity while slowing gastric emptying
